About me
Executive leader for North American regulatory affairs for Eli Lilly and Company. The organization is responsible for all US and Canadian human drugs and devices regulatory affairs, and global manufacturing regulatory affairs. Organization provides strategic and operational regulatory capabilities required for defining the strategy and requirements for support of clinical development, product development and marketed drug and device products across the company. Additionally, the organization leads external regulatory policy that shapes the US environment for innovative drug development.
